The Evolving Treatment Landscape for Atopic Dermatitis

Date: Thursday 28 September 2017
Time: 13.15-14.15
Room: Mozart Hall 1, 2, 3

Chair: Georg Stingl (Vienna, Austria)

Symposium Objectives

  1. Provide the clinician’s perspective on current challenges and future trends for the
    management of atopic dermatitis
  2. Raise awareness of the skin barrier abnormalities and chronic inflammation involved in
    the pathophysiology of atopic dermatitis
  3. Evaluate emerging clinical data for investigational agents in development for moderateto-
    severe atopic dermatitis
  4. Discuss how emerging therapies, biomarkers, and endotypes provide further insight
    into the disease evolution and into novel clinical approaches for treating patients with
    atopic dermatitis



Welcome and Introduction

Clinical Challenges and Future Directions in the Treatment of Atopic Dermatitis
Georg Stingl (Vienna, Austria)

13.35-13.55 Targeting Pathways Involved in the Pathophysiology of Atopic Dermatitis
Marjolein de Bruin-Weller (Utrecht, The Netherlands)
13.55-14.15 Translating Scientific Advances Into the Atopic Dermatitis Treatment Paradigm
Tilo Biedermann (Munich, Germany)